XML 106 R90.htm IDEA: XBRL DOCUMENT v3.24.2
Segments (Details) - Schedule of Segment of the Continuing Operations - USD ($)
 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Segment Reporting Information [Line Items]      
Revenue $ 154,541,077 $ 148,811,976 $ 164,392,555
Cost of goods 123,432,529 114,531,512 127,873,515
Gross profit 31,108,548 34,280,464 36,519,040
Selling expenses 27,385,587 29,177,163 30,876,959
General and administrative expenses 7,257,524 15,668,684 8,187,176
Impairment of long-lived assets 148,795
Stock based compensation 10,360,000
Loss from operations (3,534,563) (20,925,383) (2,693,890)
Depreciation and amortization 790,449 718,002 1,256,491
Total capital expenditures 856,665 304,016 299,473
Retail drugstores [Member] | Operating Segments [Member]      
Segment Reporting Information [Line Items]      
Revenue 75,678,470 83,351,768 84,228,492
Cost of goods 53,056,339 56,551,607 57,290,850
Gross profit 22,622,131 26,800,161 26,937,642
Selling expenses 21,680,509 23,644,339 25,186,258
General and administrative expenses 5,195,153 13,803,165 6,766,022
Impairment of long-lived assets     148,795
Stock based compensation   10,360,000  
Loss from operations (4,253,531) (21,007,343) (5,163,433)
Depreciation and amortization 754,448 686,777 1,234,419
Total capital expenditures 855,497 303,312 296,562
Online Pharmacy [Member] | Operating Segments [Member]      
Segment Reporting Information [Line Items]      
Revenue 31,857,883 32,385,089 30,219,364
Cost of goods 28,249,883 28,506,228 26,621,314
Gross profit 3,608,000 3,878,861 3,598,050
Selling expenses 4,770,855 4,266,799 3,972,465
General and administrative expenses 466,151 439,667 285,062
Impairment of long-lived assets    
Stock based compensation    
Loss from operations (1,629,006) (827,605) (659,477)
Depreciation and amortization
Total capital expenditures
Drug wholesale [Member] | Operating Segments [Member]      
Segment Reporting Information [Line Items]      
Revenue 47,004,724 33,075,119 49,944,699
Cost of goods 42,126,307 29,473,677 43,961,351
Gross profit 4,878,417 3,601,442 5,983,348
Selling expenses 934,223 1,266,025 1,718,236
General and administrative expenses 1,596,220 1,425,852 1,136,092
Impairment of long-lived assets    
Stock based compensation    
Loss from operations 2,347,974 909,565 3,129,020
Depreciation and amortization 36,001 31,225 22,072
Total capital expenditures $ 1,168 $ 704 $ 2,911